Skip to content

Parangipattai kashayam (Internal) and Sneha pottanam-Ottradam (External therapy) for Sirakambavatham (Cerebral palsy)

Phase II Non-randomized clinical study on Sirakambavatham (Cerebral palsy) with the evaluation of siddha trial drug Parangipattai kashayam as Internal medicine and Sneha pottanam (Ottradam) as External therapy. - Nil

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057888
Enrollment
40
Registered
2023-09-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G800- Spastic quadriplegic cerebral palsy

Interventions

Intervention1: Parangipattai Kashayam (Internal) and Sneha pottanam-Ottradam (External therapy): Parangipattai kashayam 5 to 10 ml twice a day for 48 days and External therapy of Sneha pottanam-Ottrad

Sponsors

Government Siddha medical college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Delay in gross motor and fine motor milestones. Delay in intellectual and cognitive functional development. Abnormal muscle tone and reflexes. Spastic quadriplegic cerebral palsy

Exclusion criteria

Exclusion criteria: Children above 12 years. Patient with severe seizure disorder. Patient with severe serious illness. CP with other congenital associated disorders. Autism spectrum disorders. Mixed type of cerebral palsy. Ataxic/Dyskinetic/Athetoid/Choreoathetoid/Dystonic cerebral palsy.

Design outcomes

Primary

MeasureTime frame
It is mainly assessed by reduction in clinical symptomsTimepoint: 48 days

Secondary

MeasureTime frame
It is assessed by comparing the sensory functions connecting parameters & improvement in motor parameters and fine motor functions of the upper limb.Timepoint: 48 days

Countries

India

Contacts

Public ContactDr T Priyanka

Government Siddha Medical College Chennai

cspriya2004@gmail.com9445661808

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026